In vivo efficacies of combinations of β-lactams, β-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1406-1411

  Wolff, Michel ^a   Joly Guillou, Marie Laure ^b   Farinotti, Robert ^a   Carbon, Claude ^a  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORINASE; IMIPENEM; RIFAMPICIN; SULBACTAM; TICARCILLIN; TIMENTIN;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0033002103     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1406     Document Type: Article

References (27)

1. Anstey, N. M., B. J. Curry, and K. M. Withnall. 1992. Community-acquired Acinetobacter pneumonia in the northern territory of Australia. Clin. Infect. Dis. 14:83-91.
2. Boon, R. J., A. Beale, and R. Sutherland. 1986. Bactericidal effects of ticarcillin-clavulanic acid against β-lactamase-producing bacteria in vivo. Antimicrob. Agents Chemother. 29:838-844.
3. Chang-Xiao, L., W. Jla-Rong, and L. Yi-Li. 1990. Pharmacokinetics of sulbactam and ampicillin in mice and in dogs. Eur. J. Pharmacol. 183:1859-1860.
4. Corbella, X., J. Ariza, C. Ardanuy, M. Vuelta, F. Tubeau, M. Sora, M. Pujol, and F. Gudiol. 1998. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J. Antimicrob. Chemother. 42:793-802.
5. Costa, S. F., J. Wodcock, J. Child, H. H. Caiafa. M. Gill, R. Wise, and A. S. Levin. 1996. Characterization of the β-lactamase and outer-membrane proteins of imipenem-resistant Acinetobacter baumannii clinical isolates from Brazil, abstr. C123, p. 56. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-12.
7. Fagon, J. Y., J. Chastre, Y. Domart, J. L. Trouillet, and C. Gibert. 1996. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species; assessment by quantitative culture of samples obtained by a protected specimen brush. Clin. Infect. Dis. 23:538-542.
8. Fantin, B., J. Pierre, N. Casléla-Papin, L. Saint-Julien, H. Drugeon, R. Farinotti, and C. Carbon. 1996. Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Slaphylococcus aureus. Antimicrob. Agents Chemother. 40:1219-1224.
9. Go, E. S., C. Urban, J. Burns, J. Kreiswirth, W. Elsner, N. Mariano, K. Mosinka-Snipas, and J. J. Rahal. 1994. Clinical and molecular epidemiology of Acinelobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344:1329-1332.
10. Greenblatt, D. J., and J. Koch-Weser. 1975. Clinical pharmacokinetics. N. Engl. J. Med. 297:702-705.
11. Itoh, T., and H. Yamada. 1995. Diastereomeric beta-lactam antibiotics: analytical methods, isomerization and stereo selective pharmacokinetic. J. Chromatogr. 694:195-208.
12. Jacobs, R F., J. M. Trang, G. L. Kearns, R. H. Warren, A. L. Brown, F. L. Underwodd, and R. B. Kluza. 1985. Ticarcillin-clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis. J. Pediatr. 106:1001-1007.
13. Joly-Guillou, M. L. 1997. Acinetobacter baumannii: sensibilité actuelle aux antibiotiques. Mécanismes de résistance. Fréquence. Lett. Infectiol. 9:399-404.
14. Joly-Guillou, M. L., D. Decré, J. L. Herrman, E. Bourdelier, and E. Bergogne-Berezin. 1995. Bactericidal in-vitro activity of β-lactams and β-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. J. Antimicrob. Chemother. 36:619-629.
15. Joly-Guillou, M. L., M. Wolf, J. J. Pocidalo, F. Walker, and C. Carbon. 1997. Use of a new model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob. Agents Chemother. 41:345-351.
16. Kucers, A., S. Crowe, M. L. Grayson, and J. Hoy. 1997. Rifampicin (rifampin), p. 676-708. In A. Kucers, S. Crowe, M. L. Grayson, and J. Hoy (ed.), The use of antibiotics. A comprehensive review with clinical emphasis, 5th ed. William Heinemann Medical Books, Oxford, United Kingdom.
17. Nordmann, P., J. J. Kerestedjian, and E. Ronco. 1992. Therapy of Rhodococcus equi disseminated infections in nude mice. Antimicrob. Agents Chemother. 36:1244-1248.
18. Obana, Y., T. Nishino, and T. Tanino. 1985. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 15:441-448.
19. Obana, Y., and T. Nishino. 1990. In-vitro and in-vivo activities of sulbactam and YTR 830H against Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 26:677-682.
20. Pearson, R. R., R. T. Steigbeigel, H. T. Davis, and S. W. Chapman. 1980. Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708.
21. Sauve, C., E. Azoulay-Dupuis, P. Moine, C. Darras-Joly, V. Rieux, C. Carbon, and J. P. Bédos. 1996. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin-and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2829-2834.
22. Shah, A. J., M. W. Adlard, and J. D. Stride. 1990. A sensitive assay for clavulanic acid and sulbactam in biological fluids by high performance liquid chromatography and pre-column derivatization. J. Pharm. Biomed. Anal. 8:437-443.
23. Shasha, B., R. Lang, and E. Rubinstein. 1992. Therapy of experimental murine brucellosis with streptomycin, cotrimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin. Antimicrob. Agents Chemother. 36:973-976.
24. Swart, K. J., and M. Papgis. 1992. Automated high performance liquid chromatographic method for determination of rifampicin in plasma. J. Chromatogr. 593:21-24.
25. Tankovic, J., P. Legrand, G. de Gatines, V. Chemineau, C. Brun-Buisson, and J. Duval. 1994. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J. Clin. Microbiol. 32:2677-2681.
26. Urban, C., E. Go, N. Mariano, B. J. Berger, I. Avraham, D. Rubin, and J. J. Rahal. 1993. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J. Infect. Dis. 167:448-451.
27. Valcke, Y. J., M. T. Roosel, R. A. Pauwells, M. G. Bogaert, and M. E. van der Straeten. 1990. Penetration of ampicillin and sulbactam in the lower airways during respiratory infections. Antimicrob. Agents Chemother. 34:958-961.